ID   NPAS3_HUMAN             Reviewed;         933 AA.
AC   Q8IXF0; Q86US6; Q86US7; Q8IXF2; Q9BY81; Q9H323; Q9Y4L8;
DT   28-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   28-JUN-2023, entry version 178.
DE   RecName: Full=Neuronal PAS domain-containing protein 3;
DE            Short=Neuronal PAS3;
DE   AltName: Full=Basic-helix-loop-helix-PAS protein MOP6;
DE   AltName: Full=Class E basic helix-loop-helix protein 12;
DE            Short=bHLHe12;
DE   AltName: Full=Member of PAS protein 6;
DE   AltName: Full=PAS domain-containing protein 6;
GN   Name=NPAS3; Synonyms=BHLHE12, MOP6, PASD6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Fetal brain;
RA   Ohe N., Saito K., Kaneko H.;
RT   "Splicing variants of human NPAS3.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RA   Thomas R.S., Bradfield C.A.;
RT   "Cloning and chromosomal localization of MOP6.";
RL   Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 4 AND 5), SUBCELLULAR LOCATION, AND
RP   CHROMOSOMAL TRANSLOCATION.
RC   TISSUE=Fetal brain;
RX   PubMed=12746393; DOI=10.1136/jmg.40.5.325;
RA   Kamnasaran D., Muir W.J., Ferguson-Smith M.A., Cox D.W.;
RT   "Disruption of the neuronal PAS3 gene in a family affected with
RT   schizophrenia.";
RL   J. Med. Genet. 40:325-332(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 58-933 (ISOFORM 6).
RG   The European IMAGE consortium;
RL   Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: May play a broad role in neurogenesis. May control regulatory
CC       pathways relevant to schizophrenia and to psychotic illness (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Efficient DNA binding requires dimerization with another bHLH
CC       protein. Interacts with ARNT; forms a heterodimer that binds core DNA
CC       sequence 5'-[AG]CGTG-3' within the hypoxia response element (HRE) of
CC       target gene promoters (By similarity). {ECO:0000250|UniProtKB:Q9QZQ0}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00981,
CC       ECO:0000269|PubMed:12746393}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=long form;
CC         IsoId=Q8IXF0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IXF0-2; Sequence=VSP_009085;
CC       Name=3; Synonyms=NPAS3v;
CC         IsoId=Q8IXF0-3; Sequence=VSP_009085, VSP_009087;
CC       Name=4;
CC         IsoId=Q8IXF0-4; Sequence=VSP_009085, VSP_009086;
CC       Name=5;
CC         IsoId=Q8IXF0-5; Sequence=VSP_009084, VSP_009086, VSP_009088,
CC                                  VSP_009089;
CC       Name=6;
CC         IsoId=Q8IXF0-6; Sequence=VSP_009088, VSP_009089;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed in the adult brain.
CC   -!- DISEASE: Note=A chromosomal aberration involving NPAS3 is found in a
CC       family with schizophrenia. Translocation t(9;14)(q34;q13).
CC       {ECO:0000269|PubMed:12746393}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB055962; BAC53756.1; -; mRNA.
DR   EMBL; AB054575; BAB21221.1; -; mRNA.
DR   EMBL; AB054576; BAC53754.1; -; mRNA.
DR   EMBL; AF164438; AAG35180.1; -; mRNA.
DR   EMBL; AY157302; AAO17043.1; -; mRNA.
DR   EMBL; AY157303; AAO17044.1; -; mRNA.
DR   EMBL; AL079281; CAB45154.1; -; mRNA.
DR   CCDS; CCDS53891.1; -. [Q8IXF0-1]
DR   CCDS; CCDS53892.1; -. [Q8IXF0-3]
DR   CCDS; CCDS55912.1; -. [Q8IXF0-2]
DR   CCDS; CCDS9645.1; -. [Q8IXF0-4]
DR   RefSeq; NP_001158221.1; NM_001164749.1. [Q8IXF0-1]
DR   RefSeq; NP_001159365.1; NM_001165893.1. [Q8IXF0-2]
DR   RefSeq; NP_071406.1; NM_022123.2. [Q8IXF0-4]
DR   RefSeq; NP_775182.1; NM_173159.2. [Q8IXF0-3]
DR   AlphaFoldDB; Q8IXF0; -.
DR   SMR; Q8IXF0; -.
DR   BioGRID; 122040; 7.
DR   IntAct; Q8IXF0; 5.
DR   MINT; Q8IXF0; -.
DR   STRING; 9606.ENSP00000348460; -.
DR   GlyCosmos; Q8IXF0; 3 sites, 1 glycan.
DR   GlyGen; Q8IXF0; 3 sites, 1 O-linked glycan (3 sites).
DR   iPTMnet; Q8IXF0; -.
DR   PhosphoSitePlus; Q8IXF0; -.
DR   BioMuta; NPAS3; -.
DR   DMDM; 38604888; -.
DR   EPD; Q8IXF0; -.
DR   MassIVE; Q8IXF0; -.
DR   PaxDb; Q8IXF0; -.
DR   PeptideAtlas; Q8IXF0; -.
DR   ProteomicsDB; 70984; -. [Q8IXF0-1]
DR   ProteomicsDB; 70985; -. [Q8IXF0-2]
DR   ProteomicsDB; 70986; -. [Q8IXF0-3]
DR   ProteomicsDB; 70987; -. [Q8IXF0-4]
DR   Antibodypedia; 136; 137 antibodies from 27 providers.
DR   DNASU; 64067; -.
DR   Ensembl; ENST00000346562.6; ENSP00000319610.5; ENSG00000151322.20. [Q8IXF0-4]
DR   Ensembl; ENST00000356141.9; ENSP00000348460.4; ENSG00000151322.20. [Q8IXF0-1]
DR   Ensembl; ENST00000357798.9; ENSP00000350446.5; ENSG00000151322.20. [Q8IXF0-3]
DR   Ensembl; ENST00000547068.5; ENSP00000449542.1; ENSG00000151322.20. [Q8IXF0-5]
DR   Ensembl; ENST00000548645.5; ENSP00000448916.1; ENSG00000151322.20. [Q8IXF0-2]
DR   GeneID; 64067; -.
DR   KEGG; hsa:64067; -.
DR   MANE-Select; ENST00000356141.9; ENSP00000348460.4; NM_001164749.2; NP_001158221.1.
DR   UCSC; uc001wrs.4; human. [Q8IXF0-1]
DR   AGR; HGNC:19311; -.
DR   CTD; 64067; -.
DR   DisGeNET; 64067; -.
DR   GeneCards; NPAS3; -.
DR   HGNC; HGNC:19311; NPAS3.
DR   HPA; ENSG00000151322; Tissue enhanced (brain).
DR   MIM; 609430; gene.
DR   neXtProt; NX_Q8IXF0; -.
DR   OpenTargets; ENSG00000151322; -.
DR   PharmGKB; PA134968746; -.
DR   VEuPathDB; HostDB:ENSG00000151322; -.
DR   eggNOG; KOG3558; Eukaryota.
DR   GeneTree; ENSGT00940000158051; -.
DR   InParanoid; Q8IXF0; -.
DR   OrthoDB; 5396877at2759; -.
DR   PhylomeDB; Q8IXF0; -.
DR   TreeFam; TF317772; -.
DR   PathwayCommons; Q8IXF0; -.
DR   SignaLink; Q8IXF0; -.
DR   BioGRID-ORCS; 64067; 13 hits in 1167 CRISPR screens.
DR   ChiTaRS; NPAS3; human.
DR   GenomeRNAi; 64067; -.
DR   Pharos; Q8IXF0; Tbio.
DR   PRO; PR:Q8IXF0; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; Q8IXF0; protein.
DR   Bgee; ENSG00000151322; Expressed in endothelial cell and 164 other tissues.
DR   ExpressionAtlas; Q8IXF0; baseline and differential.
DR   Genevisible; Q8IXF0; HS.
DR   GO; GO:0000785; C:chromatin; ISA:NTNU_SB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   CDD; cd19732; bHLH-PAS_NPAS3_PASD6; 1.
DR   CDD; cd00130; PAS; 2.
DR   Gene3D; 4.10.280.10; Helix-loop-helix DNA-binding domain; 1.
DR   Gene3D; 3.30.450.20; PAS domain; 2.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR035965; PAS-like_dom_sf.
DR   InterPro; IPR013767; PAS_fold.
DR   InterPro; IPR013655; PAS_fold_3.
DR   PANTHER; PTHR23043; HYPOXIA-INDUCIBLE FACTOR 1 ALPHA; 1.
DR   PANTHER; PTHR23043:SF30; NEURONAL PAS DOMAIN-CONTAINING PROTEIN 3; 1.
DR   Pfam; PF00989; PAS; 1.
DR   Pfam; PF08447; PAS_3; 1.
DR   SMART; SM00353; HLH; 1.
DR   SMART; SM00091; PAS; 2.
DR   SUPFAM; SSF47459; HLH, helix-loop-helix DNA-binding domain; 1.
DR   SUPFAM; SSF55785; PYP-like sensor domain (PAS domain); 2.
DR   PROSITE; PS50888; BHLH; 1.
DR   PROSITE; PS50112; PAS; 2.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Chromosomal rearrangement; DNA-binding; Nucleus;
KW   Reference proteome; Repeat; Transcription; Transcription regulation.
FT   CHAIN           1..933
FT                   /note="Neuronal PAS domain-containing protein 3"
FT                   /id="PRO_0000127408"
FT   DOMAIN          51..104
FT                   /note="bHLH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00981"
FT   DOMAIN          147..217
FT                   /note="PAS 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00140"
FT   DOMAIN          319..389
FT                   /note="PAS 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00140"
FT   DOMAIN          363..406
FT                   /note="PAC"
FT   REGION          1..24
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          53..64
FT                   /note="DNA-binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QZQ0"
FT   REGION          215..253
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          452..549
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          562..641
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          657..725
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          742..780
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        225..253
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        456..506
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        520..541
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        567..592
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        596..612
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        657..690
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         1..102
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:12746393"
FT                   /id="VSP_009084"
FT   VAR_SEQ         18..47
FT                   /note="Missing (in isoform 2, isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:12746393, ECO:0000303|Ref.1,
FT                   ECO:0000303|Ref.2"
FT                   /id="VSP_009085"
FT   VAR_SEQ         128
FT                   /note="K -> KGIQMWKSELCMRKTPCE (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_009087"
FT   VAR_SEQ         129..130
FT                   /note="Missing (in isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:12746393, ECO:0000303|Ref.2"
FT                   /id="VSP_009086"
FT   VAR_SEQ         246..257
FT                   /note="ESTSPSLLTTDN -> VCFPPASDQFLL (in isoform 5 and
FT                   isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:12746393, ECO:0000303|Ref.4"
FT                   /id="VSP_009088"
FT   VAR_SEQ         258..933
FT                   /note="Missing (in isoform 5 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:12746393, ECO:0000303|Ref.4"
FT                   /id="VSP_009089"
FT   CONFLICT        65
FT                   /note="G -> E (in Ref. 4; CAB45154)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        79..81
FT                   /note="PLP -> LS (in Ref. 4; CAB45154)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        552
FT                   /note="A -> P (in Ref. 3; AAO17043)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   933 AA;  100805 MW;  3215AC657CEDD9A9 CRC64;
     MAPTKPSFQQ DPSRRERITA QHPLPNQSEC RKIYRYDGIY CESTYQNLQA LRKEKSRDAA
     RSRRGKENFE FYELAKLLPL PAAITSQLDK ASIIRLTISY LKMRDFANQG DPPWNLRMEG
     PPPNTSVKVI GAQRRRSPSA LAIEVFEAHL GSHILQSLDG FVFALNQEGK FLYISETVSI
     YLGLSQVELT GSSVFDYVHP GDHVEMAEQL GMKLPPGRGL LSQGTAEDGA SSASSSSQSE
     TPEPVESTSP SLLTTDNTLE RSFFIRMKST LTKRGVHIKS SGYKVIHITG RLRLRVSLSH
     GRTVPSQIMG LVVVAHALPP PTINEVRIDC HMFVTRVNMD LNIIYCENRI SDYMDLTPVD
     IVGKRCYHFI HAEDVEGIRH SHLDLLNKGQ CVTKYYRWMQ KNGGYIWIQS SATIAINAKN
     ANEKNIIWVN YLLSNPEYKD TPMDIAQLPH LPEKTSESSE TSDSESDSKD TSGITEDNEN
     SKSDEKGNQS ENSEDPEPDR KKSGNACDND MNCNDDGHSS SNPDSRDSDD SFEHSDFENP
     KAGEDGFGAL GAMQIKVERY VESESDLRLQ NCESLTSDSA KDSDSAGEAG AQASSKHQKR
     KKRRKRQKGG SASRRRLSSA SSPGGLDAGL VEPPRLLSSP NSASVLKIKT EISEPINFDN
     DSSIWNYPPN REISRNESPY SMTKPPSSEH FPSPQGGGGG GGGGGGLHVA IPDSVLTPPG
     ADGAAARKTQ FGASATAALA PVASDPLSPP LSASPRDKHP GNGGGGGGGG GGAGGGGPSA
     SNSLLYTGDL EALQRLQAGN VVLPLVHRVT GTLAATSTAA QRVYTTGTIR YAPAEVTLAM
     QSNLLPNAHA VNFVDVNSPG FGLDPKTPME MLYHHVHRLN MSGPFGGAVS AASLTQMPAG
     NVFTTAEGLF STLPFPVYSN GIHAAQTLER KED
//
